Countries that approve, and will use, the Sputnik V vaccine. How much does it cost, compared to other similar products
Today EMA has paved the way for the approval of the Russian Sputnik V vaccine, the first placed on the market, even if only in Russia, and now highly sought after, also in view of the supply problems of Astra Zeneca.
So far, more than 4o countries have officially approved the use of Sputnik V and worldwide interest seems to grow in the launch of the Russian product. Compared to many of the Western alternatives, it is much more cost-effective and can be stored and transported easily without logistical constraints. This is of particular importance to dozens of poorer nations in Asia, Africa and the Americas. There are currently about one billion doses ordered from various countries around the world, including some from the EU, including Hungary and the Czech Republic. San Marino received a small batch.
There are doubts about the production capacity of the Russian pharmaceutical industries, a fear probably not unfounded, but the RDIF fund, holder of the license, has said that it is available for its transfer, even free of charge if necessary. the important thing is to vaccinate many people in a short time.
Its effectiveness, according to studies, is second only to Pfizer and Moderna. The cost is less than half of the Pfizer, while its storage takes place at two degrees, so in a normal fridge.
Here is a complete infographic of the main data on the vaccine.
Enjoy the reading
Thanks to our Telegram channel you can stay updated on the publication of new articles of Economic Scenarios.
The article Countries that approve, and will use the Sputnik V vaccine. How much does it cost, compared with other similar products, comes from ScenariEconomici.it .
This is a machine translation of a post published on Scenari Economici at the URL https://scenarieconomici.it/paesi-che-approvano-ed-utilizzeranno-il-vaccino-sputnik-v-quanto-costa-comparato-con-gli-altri-prodotti-simili/ on Tue, 16 Mar 2021 12:30:07 +0000.